A hormone treatment called tesamorelin lowers liver enzyme levels by 4 units more than a placebo in people with HIV after six months of treatment.

A daily injection called tesamorelin helps HIV patients with a big belly lose nearly 11% of their dangerous internal belly fat in six months, while those getting a fake shot don’t lose any.

HIV patients with belly fat and high liver enzymes who lost at least 8% of their visceral fat from the drug saw their ALT drop by about 9 points (18%) and AST by 4 points (10%) after six months of treatment.

A hormone treatment called tesamorelin decreases belly fat by 42 square centimeters more than a placebo in people with HIV who have excess abdominal fat after six months of treatment.

A drug called tesamorelin helps HIV patients with belly fat buildup lose about 11% of their dangerous internal belly fat in six months, while those on a dummy pill lose almost none.

HIV patients with belly fat who took tesamorelin had a 69% chance of losing at least 8% visceral fat, while those on placebo had only a 33% chance, showing a clear benefit from the drug.